Commercial development opportunities for Pharma, Biotech and Investors

The region’s largest stem cells and regenerative medicine industry conference

The stem cell and regenerative medicine industry is burgeoning to a critical mass and pioneering to
transform the future of healthcare.

Engage in a global forum with senior level decision makers at Europe’s largest executive level stem cell conference and make sure you learn from the recent successes and failures experienced during cell therapy development.

Program

DAY ONE – Plenary - Monday 21st May 2012

- Cell Therapies and innovation Centres
- Translating research and accelerating to market

DAY ONE - Stream A : Cell Therapy & Regenerative Medicine

- Advances in Clinical and the crucial lessons learned

DAY ONE : Stream B : Stem Cells for Drug Discovery

- Current landscape of iPS application
- Exploiting all stem cell types for drug discovery

DAY TWO – Plenary - Tuesday 22nd May 2012

- Successful regulatory pathways
- Reimbursement for cell therapies

DAY TWO - Stream A : Cell Therapy & Regenerative Medicine

- The reality of cell therapies for the end user
- Manufacturing towards a global scale
- Successful commercialisation following market approval

DAY TWO - Stream B : Stem Cells for Drug Discovery

- Advances in stem cells differentiation
- Identifying and validating toxicology of drugs
- Using stem cells for functional analysis and target discovery

DAY THREE - Stream A : Cell Therapy & Regenerative Medicine

- Implementing stem cells in pioneering therapeutic applications
- Cord blood banking

DAY THREE - Stream B : Stem Cells for Drug Discovery

- Industrialising stem cells for discovery
- Safety first to succeed in drug discovery
- Cancer stem cells as therapeutics targets
- Managing the future expectations of stem cells
- Stem Cell-based collaborations

DAY THREE - Plenary Session - Wednesday 23rd May 2012

- Access to funding and establising collaborations
- The value of future cell therapies

More informations